3 Alzheimers Disease Clinical Trials in Decatur, GA (2026)

Q: How do I join a clinical trial in Decatur?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Decatur research site will contact you.

Recruiting Alzheimers Disease Studies in Decatur

NCT07383441Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, pembrolizumab, cabozantinib, and lenvatin...

Decatur, GAPHASE3718 participantsSWOG Cancer Research Network

View Study Details

NCT06657768Recruiting

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY4006895. Part A will administer a single-ascending dose in healthy participants or Part B will ad...

Decatur, GAPHASE1128 participantsEli Lilly and Company

View Study Details

NCT06297590Recruiting

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

The main purpose of this study is to evaluate the safety of LY3954068 in participants with early symptomatic Alzheimer's Disease (AD). The study will also investigate how much LY3954068 gets into the ...

Decatur, GAPHASE148 participantsEli Lilly and Company

View Study Details

About Alzheimers Disease Clinical Trials in Decatur

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 3 alzheimers disease clinical trials recruiting participants in Decatur, GA. These studies are seeking a combined 894 participants. Research is being sponsored by SWOG Cancer Research Network, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Decatur — FAQ

Are there alzheimers disease clinical trials in Decatur?

Yes, there are 3 alzheimers disease clinical trials currently recruiting in Decatur, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Decatur?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Decatur research site will contact you about next steps.

Are clinical trials in Decatur free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Decatur studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 3 active trials in Decatur are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 22, 2026 from ClinicalTrials.gov